Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Terminated 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 677Neoplasms 593Colorectal Neoplasms 292Carcinoma, Non-Small-Cell Lung 292Prostatic Neoplasms 281Lung Neoplasms 223Melanoma 161Multiple Myeloma 150Neoplasm Metastasis 146Head and Neck Neoplasms 143Pancreatic Neoplasms 141Ovarian Neoplasms 133Carcinoma, Hepatocellular 126Leukemia, Myeloid, Acute 123Colonic Neoplasms 112Brain Neoplasms 112Squamous Cell Carcinoma of Head and Neck 111Uterine Cervical Neoplasms 108Stomach Neoplasms 105Recurrence 101Lymphoma 101Glioblastoma 94Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Lymphoma, Non-Hodgkin 82Hematologic Neoplasms 80Urinary Bladder Neoplasms 78Lymphoma, Follicular 78Glioma 75Parkinson Disease 4, Autosomal Dominant Lewy Body 74Leukemia, Lymphocytic, Chronic, B-Cell 72

Interventions

itacitinib 1INCB039110 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × B-cell Malignancies × 1 year × Clear all
NCT01905813 2026-05-11

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Incyte Corporation

Phase 1 Completed
121 enrolled
Lymphoid

B-cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡